Cyclacel Pharmaceuticals Inc (CYCC)
2.00
-0.48
(-19.35%)
USD |
NASDAQ |
May 03, 16:00
2.02
+0.02
(+1.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Revenue (Quarterly): 0.031M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.031M |
| September 30, 2023 | 0.016M |
| June 30, 2023 | 0.373M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.15M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.277M |
| September 30, 2016 | 0.205M |
| June 30, 2016 | 0.222M |
| March 31, 2016 | 0.139M |
| December 31, 2015 | 0.421M |
| September 30, 2015 | 0.715M |
| June 30, 2015 | 0.296M |
| March 31, 2015 | 0.512M |
| December 31, 2014 | 0.247M |
| September 30, 2014 | 0.735M |
| June 30, 2014 | 0.356M |
| March 31, 2014 | 0.396M |
| December 31, 2013 | 0.299M |
| September 30, 2013 | 0.309M |
| June 30, 2013 | 0.264M |
| March 31, 2013 | 0.212M |
| December 31, 2012 | 0.005M |
| September 30, 2012 | 0.038M |
| June 30, 2012 | 0.026M |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.016M
Minimum
Sep 2023
0.373M
Maximum
Jun 2023
0.14M
Average
0.031M
Median
Dec 2023
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.271M |
| Total Expenses (Quarterly) | 5.391M |
| EPS Diluted (Quarterly) | -6.23 |
| Enterprise Value | -0.1086M |
| Profit Margin (Quarterly) | -17.00K% |
| Earnings Yield | -1.35K% |
| Normalized Earnings Yield | -1332.65 |